# CHF Solutions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chf-solutions

- Industry: Medical Devices & Equipment
- Headquarters: Brooklyn Park, US
- Website: www.chfsolutions.com
- Total disclosed funding: $26M
- Latest round: Series D (Jul 16, 2002)
- Investors on record: 5

## About

CHF Solutions specializes in innovative medical technology focused on fluid management for patients with acute heart failure, offering advanced solutions to enhance patient care and outcomes.CHF Solutions, founded in 1999, is based in Brooklyn Park, US, and develops medical devices designed to address fluid management in heart failure patients. The company has undergone strategic changes but operates independently. Nestor Jaramillo serves as CEO. The company has raised a total of USD 26.20 mn through 4 funding deals, with the latest funding round being a VENTURE DEBT round of USD 22.90 mn on January 20, 2010, with investors including Brightstone Venture Capital and Kaiser Permanente Ventures.CHF Solutions focuses on innovative medical technology aimed at addressing fluid management in patients with acute heart failure. The company’s flagship product, the Aquadex FlexFlow system, provides ultrafiltration therapy, effectively removing excess fluid from patients' bodies to alleviate heart failure symptoms. This system operates through a bedside device connected to a patient's central venous catheter, allowing healthcare providers to control fluid removal rates tailored to individual patient needs. It primarily serves hospitals and healthcare facilities, catering to cardiologists, critical care units, and nephrologists across North America and select European markets, aiming to improve patient outcomes and quality of life while supporting healthcare professionals in managing complex conditions.CHF Solutions generates revenue primarily through direct sales of its medical devices to healthcare institutions, concentrating on hospitals treating heart failure patients. The business-to-business model involves partnerships with healthcare providers and distributors to enhance market reach. Revenue is realized through sales of the Aquadex FlexFlow system and associated consumables, creating a recurring revenue stream. Pricing strategies align with the complexity of the device and supportive services offered, ensuring compatibility with healthcare budgets and patient care standards, thus facilitating long-term relationships with providers.CHF Solutions plans to leverage its recent VENTURE DEBT funding of USD 22.90 mn to support the development and launch of new products aimed at expanding its offerings in fluid management technology. The company also seeks to penetrate new markets in Europe and Asia by 2025, aiming to broaden its geographic reach and enhance its impact on patient care. The funding will be strategically allocated to product development, market expansion activities, and strengthening partnerships with healthcare providers.

## Funding rounds

- Series D, Jul 16, 2002, $26M — Mason Wells, Zesiger Capital Group, Patricia Industries, Brightstone Venture Capital, MPM BioImpact

## Investors

- Mason Wells (https://capitalatlas.ai/funds/mason-wells) — Series D
- Zesiger Capital Group (https://capitalatlas.ai/funds/zesiger-capital-group) — Series D
- Patricia Industries (https://capitalatlas.ai/funds/patricia-industries) — Series D
- Brightstone Venture Capital (https://capitalatlas.ai/funds/brightstone-venture-capital) — Series D
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series D